Back to Rankings

EQ

EquilliumD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
EQ vs peer average
41/100
EQ vs. peer average (D vs. C)
Grade spread
A 1 · B 3 · D 4 · F 3
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

STRO is the first available peer comparator.

Loose comparator: small-cap clinical-stage biotech with heavy financing sensitivity and event-driven volatility, useful for gauging how cash runway and trial timing drive valuation swings.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerSTROSutro Biopharma
EQ
Equillium
STRO
Sutro Biopharma
Grade
D
D
Momentum
88
31
Value
41
41
Sentiment
8
64
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive

Grade position vs STRO

EQ / STRO
Grade Position
Below peers
EQ vs. peer average (D vs. C)
41/100
Momentum
88
EQ
Value
41
EQ
Sentiment
8
STRO

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs EQ
1
STRO
STRO
D
40/100
Even
2
DTIL
DTIL
B
80/100
-2
3
MSLE
MSLE
F
20/100
+1
4
IMDX
Insight Molecular Diagnostics Inc Common
F
20/100
+1
5
LENZ
LENZ Therapeutics Inc Common
B
80/100
-2
STRO is the first peer returned for this comparison set.